Log in / Register Soon
Official Education Partner of the Delhi Medicos Premier League — free question bank for every player and college
SN5 SHORT NOTE 5M ★ High-yield

Describe carcinoma of the urinary bladder with its aetiology, morphology and clinical features.

Pathology · 2nd Professional — Para-Clinical

Introduction

Urothelial (transitional cell) carcinoma accounts for over 90% of bladder tumours, and may arise anywhere the urothelium is found — renal pelvis, ureter, bladder and proximal urethra.

  • Male to female ratio about 3:1; usually over 50
  • A "field change" disease — the whole urothelium is exposed to the same carcinogens, so tumours are frequently multifocal and recurrent, which dictates lifelong surveillance

Aetiology

FactorDetail
SmokingThe single greatest risk, responsible for about half of cases; a three- to sevenfold increase
Occupational aromatic aminesBeta-naphthylamine and benzidine — aniline dye, rubber, leather, printing and textile industries; latency of 15 to 40 years
Schistosoma haematobiumChronic infestation causes squamous metaplasia and then squamous cell carcinoma; important in Egypt and parts of Africa
Chronic irritationLong-term catheterisation, bladder stones, recurrent infection — also predispose to squamous carcinoma
Drugs and radiationCyclophosphamide (through acrolein, which also causes haemorrhagic cystitis), phenacetin abuse, pelvic radiotherapy
OtherBladder exstrophy (adenocarcinoma); urachal remnants (adenocarcinoma)

Morphology and Behaviour

CategoryFeaturesBehaviour
Papillary non-invasive (low grade)Delicate branching fronds with a fibrovascular core; orderly urotheliumRecurs often but rarely invades; good prognosis
Papillary high gradeDisordered, pleomorphic urothelium with mitoses at all levelsSignificant risk of invasion
Carcinoma IN situ (flat)Flat, high-grade dysplasia with no papillary structure; may look like harmless erythema or be invisible cystoscopicallyHigh risk of progression to invasive disease — far more dangerous than its appearance suggests
InvasiveInvades the lamina propria, then the muscularis propria (detrusor)Invasion of muscle is the critical prognostic division

CLINICAL PEARL

  • Muscle invasion is the single most important fact about a bladder tumour.
  • Non-muscle-invasive disease is managed endoscopically with intravesical treatment and surveillance, and most patients keep their bladder.
  • Muscle-invasive disease requires radical cystectomy or radiotherapy and carries a far worse prognosis. This is why the resection specimen must include detrusor muscle — a biopsy without it cannot answer the question that matters.

Clinical Features and Investigation

  • Painless gross haematuria is the classical presentation, present in about 85%; it is often intermittent, and a single episode demands full investigation
  • Frequency, urgency and dysuria suggest carcinoma in situ or a trigonal tumour, and are easily mistaken for infection
  • Obstruction of a ureteric orifice causes hydronephrosis and may present as renal impairment
  • Cystoscopy with biopsy is the definitive investigation; urine cytology is useful for high-grade tumours and carcinoma in situ, which shed abnormal cells, but often misses low-grade papillary tumours
  • CT urography images the upper tracts, which must always be assessed because of the field effect

Applied Aspects

  • Painless haematuria in an adult is bladder cancer until proved otherwise — it must never be attributed to infection or to anticoagulation without investigation
  • Transurethral resection with intravesical BCG or mitomycin for non-muscle-invasive disease; BCG provokes a local immune response and is particularly effective for carcinoma in situ
  • Lifelong cystoscopic surveillance is essential because of the high recurrence rate; this makes bladder cancer among the most expensive cancers to manage per patient
  • Radical cystectomy with urinary diversion, or radical radiotherapy, for muscle-invasive disease, with neoadjuvant chemotherapy
  • Smoking cessation reduces the risk of recurrence as well as of the first tumour, and is part of treatment rather than merely advice
  • In India, chronic catheterisation, stones and infection make squamous cell carcinoma relatively more common than in Western series

All questions in Renal & Genitourinary Pathology

  1. Q1Describe the mechanisms of glomerular injury. Differentiate the nephritic from the nephrotic syndrome and add a note on rapidly progressive glomerulonephritis. ★
  2. Q2Define nephrotic syndrome. Describe its pathophysiology, causes, morphology and complications. ★
  3. Q3Classify acute kidney injury. Describe acute tubular necrosis with its types, morphology and clinical course. ★
  4. Q4Describe acute and chronic pyelonephritis. Add a note on chronic kidney disease and its systemic consequences. ★
  5. Q5Classify renal tumours. Describe renal cell carcinoma and Wilms tumour. ★
  6. SN1Describe acute post-streptococcal glomerulonephritis with its pathogenesis and morphology. ★
  7. SN2Classify renal calculi. Describe their pathogenesis and complications. ★
  8. SN3Classify cystic diseases of the kidney. Describe adult polycystic kidney disease. ★
  9. SN4Differentiate benign prostatic hyperplasia from carcinoma of the prostate. ★
  10. SN5Describe carcinoma of the urinary bladder with its aetiology, morphology and clinical features. ★
  11. SN6Describe diabetic nephropathy with its pathogenesis, morphology and clinical stages. ★
  12. SN7Classify testicular tumours. Differentiate seminoma from non-seminomatous germ cell tumours.

Every Pathology chapter →

Scroll to Top